BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19464765)

  • 1. [Evaluation of the "Early detection and opportune attention of cervicouterine cancer" program].
    Aparicio Llanos A; Morera Salas M
    Aten Primaria; 2009 Jun; 41(6):300-5. PubMed ID: 19464765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
    Momberg M; Botha MH; Van der Merwe FH; Moodley J
    BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agreement between cytology, colposcopy and cervical histopathology].
    Katz LM; Souza AS; Fittipaldi SO; Santos Gde M; Amorim MM
    Rev Bras Ginecol Obstet; 2010 Aug; 32(8):368-73. PubMed ID: 21180872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic factors associated with cervical cancer screening coverage and follow-up of high grade abnormal results in a population-based cohort.
    Elit L; Saskin R; Raut R; Elliott L; Murphy J; Marrett L
    Gynecol Oncol; 2013 Jan; 128(1):95-100. PubMed ID: 23085459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.].
    Peccatte É; Vallée J; Trombert B; Savall A
    Sante Publique; 2018; 30(4):527-532. PubMed ID: 30540142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.
    Holmström O; Linder N; Kaingu H; Mbuuko N; Mbete J; Kinyua F; Törnquist S; Muinde M; Krogerus L; Lundin M; Diwan V; Lundin J
    JAMA Netw Open; 2021 Mar; 4(3):e211740. PubMed ID: 33729503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
    Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
    Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Overuse of colposcopy service in Mexico].
    Madrigal de la Campa Mde L; Lazcano Ponce EC; Infante Castañeda C
    Ginecol Obstet Mex; 2005 Dec; 73(12):637-47. PubMed ID: 16583841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cancer of the cervix with simultaneous pap smear and colposcopy. The efficacy of pap smear and colposcopy.
    Kuramoto H; Sugimoto N; Iida M
    Eur J Gynaecol Oncol; 2011; 32(1):73-6. PubMed ID: 21446330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
    Valdini A; Vaccaro C; Pechinsky G; Abernathy V
    J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological outcomes of women with abnormal cervical cytology: a review of literature in Thailand.
    Kietpeerakool C; Tangjitgamol S; Srisomboon J
    Asian Pac J Cancer Prev; 2014; 15(16):6489-94. PubMed ID: 25169475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the body mass index and abnormal pap smears.
    Prompakay R; Promthet S; Kamsa-Ard S; Suwanrungruang K; Wiangnon S; Bradshaw P
    Asian Pac J Cancer Prev; 2013; 14(9):5503-6. PubMed ID: 24175849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
    Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
    JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.
    Nakamura Y; Matsumoto K; Satoh T; Nishide K; Nozue A; Shimabukuro K; Endo S; Nagai K; Oki A; Ochi H; Morishita Y; Noguchi M; Yoshikawa H
    Int J Clin Oncol; 2015 Oct; 20(5):974-81. PubMed ID: 25652908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Access to uterine cervical cytology in a health region: invisible women and vulnerable bodies].
    Fernandes NFS; Galvão JR; Assis MMA; Almeida PF; Santos AMD
    Cad Saude Publica; 2019; 35(10):e00234618. PubMed ID: 31596403
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.